Dexmedetomidine Promotes SH-SY5Y Cell Resistance Against Impairment of Iron Overload by Inhibiting NF-κB Pathways
- 175 Downloads
Iron overload is a common pathophysiological state underlying many diseases that has a detrimental influence on cells. The protective effects of Dexmedetomidine (Dex), a high selective alpha-2-adrenoceptor agonist, have been revealed through many experimental models, whereas no study reports its effects on an iron overload model. To elucidate these effects, we used FeCl2 with or without Dex to treat SH-SY5Y cells for 24 h and then detected indicators of oxidative stress, inflammation and apoptosis and investigated possible mechanisms further. After treatment with FeCl2 for 24 h, cell viability decreased in a dose dependent manner, and Dex promoted cell survival in FeCl2 incubation, also in a dose-dependent manner. Compared with the FeCl2 group, 20 µM Dex significantly attenuated ROS accumulation, reduced pro-inflammatory cytokine expression, and inhibited apoptosis. Furthermore, 20 µM concentration of Dex remarkably downregulated the expression of pro-apoptotic protein and activation of caspase 3 while increasing anti-apoptotic protein expression. Additionally, Dex also effectively suppressed the expression of NF-κB and its activation. In conclusion, Dex exerted anti-oxidative stress, anti-inflammation, and anti-apoptosis effects on FeCl2-treated SH-SY5Y cells, possibly by inhibiting NF-κB signaling pathway.
KeywordsIron overload Dexmedetomidine Oxidative stress Inflammation Apoptosis NF-κB
Compliance with Ethical Standards
Conflict of interest
The authors declare that they have no conflicts of interest.
- 1.Tarifeno-Saldivia E, Aguilar A, Contreras D, Mercado L, Morales-Lange B, Marquez K, Henriquez A, Riquelme-Vidal C, Boltana S (2018) Iron overload is associated with oxidative stress and nutritional immunity during viral infection in fish. Front Immunol 9:1296CrossRefPubMedPubMedCentralGoogle Scholar
- 18.Cui ZW, Xie ZX, Wang BF, Zhong ZH, Chen XY, Sun YH, Sun QF, Yang GY, Bian LG (2015) Carvacrol protects neuroblastoma SH-SY5Y cells against Fe(2+)-induced apoptosis by suppressing activation of MAPK/JNK-NF-kappaB signaling pathway. Acta Pharmacol Sin 36:1426–1436CrossRefPubMedPubMedCentralGoogle Scholar
- 25.Breuer T, Bleilevens C, Rossaint R, Marx G, Gehrenkemper J, Dierksen H, Delpierre A, Weis J, Gayan-Ramirez G, Bruells CS (2018) Dexmedetomidine impairs diaphragm function and increases oxidative stress but does not aggravate diaphragmatic atrophy in mechanically ventilated rats. Anesthesiology 128:784–795CrossRefPubMedGoogle Scholar
- 26.Heil LB, Santos CL, Santos RS, Samary CS, Cavalcanti VC, Araujo MM, Poggio H, Maia LA, Trevenzoli IH, Pelosi P, Fernandes FC, Villela NR, Silva PL, Roccoet PR (2016) The effects of short-term propofol and dexmedetomidine on lung mechanics, histology, and biological markers in experimental obesity. Anesth Analg 122:1015–1023CrossRefPubMedGoogle Scholar